BeyondSpring BYSI
NASDAQ BYSI
$0.43 -0.01 (-3.15%)
At close: Oct 23, 2026 · 4:00 PM EDT

BeyondSpring (BYSI) Return on Sales [ROS] (2020 - 2024)

Updated

BeyondSpring's Return on Sales [ROS] came in at -5191.12% for Q3 2024, down 222.68 percentage points from the prior quarter.

Analysis

BeyondSpring (BYSI) Return on Sales [ROS] (2020 - 2024) Analysis & Trends

For FY2022, BeyondSpring's Return on Sales [ROS] was -2756.40%, up 2146.63 percentage points from FY2021.

  • Going back by year, Return on Sales [ROS] was -4903.03% in FY2021 (+30769.74 pp) and -35672.78% in FY2020.
  • The Q3 2024 figure represents the lowest quarterly Return on Sales [ROS] since Q3 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 24.35%
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 37.86%
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn -3.52%
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 32.97%
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 20.57%
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 34.95%
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -133.21%
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 28.37%
10 BeyondSpring 17.74 Mn 11.21 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 -5,191.12%
Jun 30, 2024 -4,968.44%
Mar 31, 2024 -5,022.21%
Dec 31, 2021 -3,104.14%
Sep 30, 2021 -5,444.81%
Jun 30, 2021 -5,910.95%
Mar 31, 2021 -5,153.85%
Dec 31, 2020 -10,341.67%
API Access

BeyondSpring Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=BYSI&period=max&api_key=YOUR_API_KEY